This discrepancy will not be shared with other dopamine reuptake inhbitors like bupropion, sibutramine, mazindol or tesofensine, that have related or higher potencies than copyright as dopamine reuptake inhibitors. These conclusions have evoked a speculation that copyright might also function being a so-called "DAT inverse agonist" or "negative all